97 related articles for article (PubMed ID: 17415879)
1. Inhibition of bone resorption in cultures of mouse calvariae by apicularen A.
Hong J; Sasaki H; Niikura K; Yanai M; Nakano Y; Yokomakura A; Ishihara K; Hirasawa N; Kang YS; Oh JS; Kwak JH; Zee O; Ohuchi K
Planta Med; 2007 Feb; 73(2):173-5. PubMed ID: 17415879
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of vacuolar-type (H+)-ATPase by the cytostatic macrolide apicularen A and its role in apicularen A-induced apoptosis in RAW 264.7 cells.
Hong J; Yokomakura A; Nakano Y; Ishihara K; Kaneda M; Onodera M; Nakahama K; Morita I; Niikura K; Ahn JW; Zee O; Ohuchi K
FEBS Lett; 2006 May; 580(11):2723-30. PubMed ID: 16647709
[TBL] [Abstract][Full Text] [Related]
3. Archazolid and apicularen: novel specific V-ATPase inhibitors.
Huss M; Sasse F; Kunze B; Jansen R; Steinmetz H; Ingenhorst G; Zeeck A; Wieczorek H
BMC Biochem; 2005 Aug; 6():13. PubMed ID: 16080788
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis by apicularen A in human promyelocytic leukemia cell line HL-60.
Hong J; Ishihara K; Zee O; Ohuchi K
Planta Med; 2005 Apr; 71(4):306-12. PubMed ID: 15856405
[TBL] [Abstract][Full Text] [Related]
5. Apicularens A and B, new cytostatic macrolides from Chondromyces species (myxobacteria): production, physico-chemical and biological properties.
Kunze B; Jansen R; Sasse F; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1998 Dec; 51(12):1075-80. PubMed ID: 10048565
[TBL] [Abstract][Full Text] [Related]
6. The binding site of the V-ATPase inhibitor apicularen is in the vicinity of those for bafilomycin and archazolid.
Osteresch C; Bender T; Grond S; von Zezschwitz P; Kunze B; Jansen R; Huss M; Wieczorek H
J Biol Chem; 2012 Sep; 287(38):31866-76. PubMed ID: 22815478
[TBL] [Abstract][Full Text] [Related]
7. A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application.
Niikura K; Takeshita N; Takano M
J Bone Miner Res; 2005 Sep; 20(9):1579-88. PubMed ID: 16059630
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis of RAW 264.7 cells by the cytostatic macrolide apicularen A.
Hong J; Yamaki K; Ishihara K; Ahn JW; Zee O; Ohuchi K
J Pharm Pharmacol; 2003 Sep; 55(9):1299-306. PubMed ID: 14604474
[TBL] [Abstract][Full Text] [Related]
9. Bovine parathyroid hormone enhances osteoclast bone resorption by modulating V-ATPase through PTH1R.
Liu S; Zhu W; Li S; Ma J; Zhang H; Li Z; Zhang L; Zhang B; Li Z; Liang X; Shi W
Int J Mol Med; 2016 Feb; 37(2):284-92. PubMed ID: 26647715
[TBL] [Abstract][Full Text] [Related]
10. Stereochemical determination of Archazolid A and B, highly potent vacuolar-type ATPase inhibitors from the Myxobacterium Archangium gephyra.
Hassfeld J; Farès C; Steinmetz H; Carlomagno T; Menche D
Org Lett; 2006 Oct; 8(21):4751-4. PubMed ID: 17020294
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae.
al-Humidan A; Ralston SH; Hughes DE; Chapman K; Aarden L; Russell RG; Gowen M
J Bone Miner Res; 1991 Jan; 6(1):3-8. PubMed ID: 2048428
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of V-ATPases: old and new players.
Huss M; Wieczorek H
J Exp Biol; 2009 Feb; 212(Pt 3):341-6. PubMed ID: 19151208
[TBL] [Abstract][Full Text] [Related]
13. Concanamycin B, a vacuolar H(+)-ATPase specific inhibitor suppresses bone resorption in vitro.
Woo JT; Ohba Y; Tagami K; Sumitani K; Yamaguchi K; Tsuji T
Biol Pharm Bull; 1996 Feb; 19(2):297-9. PubMed ID: 8850326
[TBL] [Abstract][Full Text] [Related]
14. Effects of Bafilomycin A1: an inhibitor of vacuolar H (+)-ATPases on endocytosis and apoptosis in RAW cells and RAW cell-derived osteoclasts.
Xu J; Feng HT; Wang C; Yip KH; Pavlos N; Papadimitriou JM; Wood D; Zheng MH
J Cell Biochem; 2003 Apr; 88(6):1256-64. PubMed ID: 12647307
[TBL] [Abstract][Full Text] [Related]
15. V-ATPase inhibitors and implication in cancer treatment.
Pérez-Sayáns M; Somoza-Martín JM; Barros-Angueira F; Rey JM; García-García A
Cancer Treat Rev; 2009 Dec; 35(8):707-13. PubMed ID: 19758758
[TBL] [Abstract][Full Text] [Related]
16. Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor.
Divieti P; John MR; Jüppner H; Bringhurst FR
Endocrinology; 2002 Jan; 143(1):171-6. PubMed ID: 11751606
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
Lerner UH
J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770
[TBL] [Abstract][Full Text] [Related]
18. A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase.
Niikura K; Takano M; Sawada M
Br J Pharmacol; 2004 Jun; 142(3):558-66. PubMed ID: 15148249
[TBL] [Abstract][Full Text] [Related]
19. Cruentaren A, a highly cytotoxic benzolactone from Myxobacteria is a novel selective inhibitor of mitochondrial F1-ATPases.
Kunze B; Sasse F; Wieczorek H; Huss M
FEBS Lett; 2007 Jul; 581(18):3523-7. PubMed ID: 17624334
[TBL] [Abstract][Full Text] [Related]
20. Formal total synthesis of (-)-apicularen A via transannular conjugate addition.
Hilli F; White JM; Rizzacasa MA
Org Lett; 2004 Apr; 6(8):1289-92. PubMed ID: 15070319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
